BRCA1 and breast carcinoma: Identifying the clinical features of BRCA1 gene hypermethylation in breast cancer patients is currently considered a major open question, since the definition of the clinical traits of this molecular signature could help oncologists to address methylated patients with dedicated treatment options and follow-up.